Global Market for Anticoccidial Drugs Is Estimated To Reach $2.85 Billion by 2020 At A CAGR Of 3.67%

Global Market for Anticoccidial Drugs Is Estimated To Reach $2.85 Billion by 2020 At A CAGR Of 3.67%

Coccidiosis Infection – A parasitic infectious disease

Coccidiosis or Coccidiasina is a parasitic type of infection that is caused by the Coccidia parasite, which can infect all mammals including birds, fish, reptiles and amphibians. This disease spreads from one animal to another when the concerned animal or animals’ is exposed to infected excrement or consumption of infected tissue. The disease infects a wide variety of animals such as cattle, poultry species, pigs and sheep with symptoms that include diarrhea varying in severity from watery manure to containing blood in their feces. Anticoccidial drugs infection is responsible for losses in animal productivity (milk production, weight gain, altered carcass composition and conception rate etc)

Anticoccidial Drugs Market Growth – An Analysis

To overcome the Coccidiosis infection, Anticoccidial drugs play an important role in the prevention and treatment of Coccidiosis. Anticoccidial drugs are an effective way of treating animals during an outbreak of Coccidiosis in calves and feeder cattle through mass medication treatment.  The Global Anticoccidial Drugs Market is estimated to reach $2.85 billion by the end of 2020 with a CAGR of 3.67% due to an increase in global population leading to rising in the per capita global consumption of meat, an increased adoption of intensive farming methods and an increased expenditure spending on companion animals. These factors are resulting in a growing usage of Anticoccidial drugs in both developed as well as developing economies.

The global Anticoccidial drugs market analysis reveals that the Asia-Pacific region to be the next hub for Anticoccidial drugs in terms of total revenue in this market by the end of 2020. The Asia-Pacific market for Anticoccidial drugs has shown a growth rate of CAGR of 8.4% from 2012 to 2014 with China emerging as the leading contributor in this region. The increased demand for meat production and meat proteins has increased the demand for Anticoccidial drugs in this region. In addition, the price war among small players in the market with cheap alternatives is giving big players like Multinational Companies a run for their money.

Over the period of two decades, Coccidiosis has become one of the most costly diseases to beat and is affecting the global poultry and meat market causing heavy losses in millions of dollars and the Anticoccidial drug market focus lies on the prevention and treatment of animal species from Coccidiosis infections. The Anticoccidial drug market is currently facing saturation in the developing markets with the major players having shifted their focus to South America and to the untapped markets of Africa and some countries in Asia-Pacific region.

Segmentation of Anticoccidial Drug Market – An overview

The Anticoccidial drug market is classified or segmented based on the types of animals and types of drugs with the animal segment further subcategorized into swine, poultry, cattle, fish and companion animals. The companion animals are further divided into dogs and cats. Under the types of drugs includes antibiotics, ionophore anticoccidials, and chemical derivative anticoccidials. By geographic region, the Anticoccidial drug market is divided into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

The countries that are emerging as the major contributors from Asia-Pacific region are China, India, Japan and Australia. The global players and new entrants are planning to enter the market by entering into joint ventures or collaborations with local companies especially in developing economies so that they can have their share of the market in Anticoccidial drugs market.

Currently, North America dominates the global Anticoccidial drugs market due to the extensive usage of anticoccidials in animal feed. The United States of America holds the largest market share for Anticoccidial drugs closely followed by Canada, Mexico, and Europe. There are also diverse challenges being faced by the anticoccidial drug market in the form of various governmental regulations especially in countries like United States of America, Europe in addition to issues related to microbial resistance build up.

These companies are expanding and extending their operations to countries of Asia-Pacific region in the form of various marketing strategies such as tie-ups, IPOs etc.

 
This press release has been viewed 75 times on PR Buzz.